Extensions for Using Data Elements from FHIR DSTU2 in FHIR R5
0.1.0 - STU
Extensions for Using Data Elements from FHIR DSTU2 in FHIR R5
0.1.0 - STU
Extensions for Using Data Elements from FHIR DSTU2 in FHIR R5 - Downloaded Version null See the Directory of published versions
| Page standards status: Trial-use | Maturity Level: 0 |
{
"resourceType" : "ValueSet",
"id" : "R2-v3-substanceAdminSubstitution-for-R5",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet R2-v3-substanceAdminSubstitution-for-R5</b></p><a name=\"R2-v3-substanceAdminSubstitution-for-R5\"> </a><a name=\"hcR2-v3-substanceAdminSubstitution-for-R5\"> </a><p>This value set expansion contains 10 concepts.</p><table class=\"codes\"><tr><td><b>System</b></td><td><b>Version</b></td><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a name=\"R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-BC\"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style=\"white-space:nowrap\">\u00a0\u00a0<a href=\"CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-BC\">BC</a></td><td>brand composition</td><td>Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven</td></tr><tr><td><a name=\"R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-E\"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style=\"white-space:nowrap\">\u00a0\u00a0<a href=\"CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-E\">E</a></td><td>equivalent</td><td>Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.</td></tr><tr><td><a name=\"R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-EC\"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style=\"white-space:nowrap\">\u00a0\u00a0<a href=\"CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-EC\">EC</a></td><td>equivalent composition</td><td>Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril</td></tr><tr><td><a name=\"R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-F\"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style=\"white-space:nowrap\">\u00a0\u00a0<a href=\"CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-F\">F</a></td><td>formulary</td><td>Description: This substitution was performed or is permitted based on formulary guidelines.</td></tr><tr><td><a name=\"R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-G\"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style=\"white-space:nowrap\">\u00a0\u00a0<a href=\"CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-G\">G</a></td><td>generic composition</td><td>Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)</td></tr><tr><td><a name=\"R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-N\"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style=\"white-space:nowrap\">\u00a0\u00a0<a href=\"CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-N\">N</a></td><td>none</td><td>No substitution occurred or is permitted.</td></tr><tr><td><a name=\"R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-TB\"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style=\"white-space:nowrap\">\u00a0\u00a0<a href=\"CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-TB\">TB</a></td><td>therapeutic brand</td><td>Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > Examples: Zantac for Tagamet</td></tr><tr><td><a name=\"R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-TE\"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style=\"white-space:nowrap\">\u00a0\u00a0<a href=\"CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-TE\">TE</a></td><td>therapeutic alternative</td><td>Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet</td></tr><tr><td><a name=\"R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-TG\"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style=\"white-space:nowrap\">\u00a0\u00a0<a href=\"CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-TG\">TG</a></td><td>therapeutic generic</td><td>Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > Examples: Ranitidine for cimetidine</td></tr><tr><td><a name=\"R2-v3-substanceAdminSubstitution-for-R5-http://hl7.org/fhir/v3/substanceAdminSubstitution-_ActSubstanceAdminSubstitutionCode\"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style=\"white-space:nowrap\">\u00a0\u00a0<a href=\"CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-_ActSubstanceAdminSubstitutionCode\">_ActSubstanceAdminSubstitutionCode</a></td><td>ActSubstanceAdminSubstitutionCode</td><td>Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.</td></tr></table></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "fhir"
},
{
"extension" : [
{
"url" : "packageId",
"valueId" : "hl7.fhir.uv.xver-r2.r5"
},
{
"url" : "version",
"valueString" : "0.1.0"
},
{
"url" : "uri",
"valueUri" : "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r5"
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/package-source"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger" : 0,
"_valueInteger" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical" : "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r5"
}
]
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode" : "trial-use",
"_valueCode" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical" : "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r5"
}
]
}
}
],
"url" : "http://hl7.org/fhir/uv/xver/ValueSet/R2-v3-substanceAdminSubstitution-for-R5",
"version" : "0.1.0",
"name" : "R2V3SubstanceAdminSubstitutionForR5",
"title" : "Cross-version ValueSet DSTU2.v3 Code System substanceAdminSubstitution for use in FHIR R5",
"status" : "active",
"experimental" : false,
"date" : "2026-03-17T21:02:03.8104715+00:00",
"publisher" : "FHIR Infrastructure",
"contact" : [
{
"name" : "FHIR Infrastructure",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/fiwg"
}
]
}
],
"description" : "This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31` for use in FHIR R5.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code" : "001",
"display" : "World"
}
]
}
],
"purpose" : "This value set is part of the cross-version definitions generated to enable use of the\r\nvalue set `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31` as defined in FHIR DSTU2\r\nin FHIR R5.\r\n\r\nThe source value set is bound to the following FHIR DSTU2 elements:\r\n* \r\n\r\nNote that all concepts are included in this cross-version definition because no concepts have compatible representations\r\n\r\nFollowing are the generation technical comments:\r\n\nFHIR ValueSet `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31`, defined in FHIR DSTU2 does not have any mapping to FHIR R5",
"compose" : {
"include" : [
{
"system" : "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version" : "1.0.2",
"concept" : [
{
"code" : "BC",
"display" : "brand composition"
},
{
"code" : "E",
"display" : "equivalent"
},
{
"code" : "EC",
"display" : "equivalent composition"
},
{
"code" : "F",
"display" : "formulary"
},
{
"code" : "G",
"display" : "generic composition"
},
{
"code" : "N",
"display" : "none"
},
{
"code" : "TB",
"display" : "therapeutic brand"
},
{
"code" : "TE",
"display" : "therapeutic alternative"
},
{
"code" : "TG",
"display" : "therapeutic generic"
},
{
"code" : "_ActSubstanceAdminSubstitutionCode",
"display" : "ActSubstanceAdminSubstitutionCode"
}
]
}
]
},
"expansion" : {
"timestamp" : "2026-03-17T21:02:03.8104715+00:00",
"contains" : [
{
"system" : "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version" : "1.0.2",
"code" : "BC",
"display" : "brand composition"
},
{
"system" : "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version" : "1.0.2",
"code" : "E",
"display" : "equivalent"
},
{
"system" : "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version" : "1.0.2",
"code" : "EC",
"display" : "equivalent composition"
},
{
"system" : "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version" : "1.0.2",
"code" : "F",
"display" : "formulary"
},
{
"system" : "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version" : "1.0.2",
"code" : "G",
"display" : "generic composition"
},
{
"system" : "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version" : "1.0.2",
"code" : "N",
"display" : "none"
},
{
"system" : "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version" : "1.0.2",
"code" : "TB",
"display" : "therapeutic brand"
},
{
"system" : "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version" : "1.0.2",
"code" : "TE",
"display" : "therapeutic alternative"
},
{
"system" : "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version" : "1.0.2",
"code" : "TG",
"display" : "therapeutic generic"
},
{
"system" : "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version" : "1.0.2",
"code" : "_ActSubstanceAdminSubstitutionCode",
"display" : "ActSubstanceAdminSubstitutionCode"
}
]
}
}
IG © 2025+ FHIR Infrastructure. Package hl7.fhir.uv.xver-r2.r5#0.1.0 based on FHIR 5.0.0. Generated 2026-03-20
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change